Cardiovascular effects of a specific nonpeptide antagonist of substance-p (nk-1) receptor in doca-salt hypertension

Detalhes bibliográficos
Autor(a) principal: Kohlmann Junior, Osvaldo [UNIFESP]
Data de Publicação: 1995
Outros Autores: Ginoza, Milton [UNIFESP], Cesaretti, Mario Luis Ribeiro [UNIFESP], Zanella, Maria Teresa [UNIFESP], Ribeiro, Artur Beltrame [UNIFESP], Ramos, Oswaldo Luiz [UNIFESP], Leeman, Susan E., Gavras, Irene, Gavras, Haralambos [UNIFESP], Tavares, Agostinho [UNIFESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: https://doi.org/10.1161/01.HYP.26.6.1186
https://repositorio.unifesp.br/handle/11600/43826
Resumo: The neurotransmitter substance P acts also as a potent vasodilator. Its participation in the pathogenesis of deoxycorticosterone acetate (DOCA)-salt hypertension was evaluated by an acute infusion of a newly synthesized, potent, specific nonpeptide antagonist of substance P at the NK-1 receptor, the agent CP 96 345. In conscious unrestrained rats, CP 96 345 induced significant and sustained increases in mean arterial pressure of DOCA-salt rats but only small, transient, and nonsignificant rises in blood pressure of sham-treated control rats. The rise in blood pressure was not accompanied by changes in heart rate. Maximal blood pressure increase in DOCA-salt rats was 31.7+/-14.8 mm Hg. In a second series of experiments, the hemodynamic effects of this antagonist were evaluated under anesthesia in both DOCA-salt and sham-treated control rats by the thermodilution method. During CP 96 345 infusion, sustained increases in cardiac index and stroke volume and decreases in total peripheral resistance were observed in both DOCA-salt and control rats. In DOCA-salt rats, cardiac index rose by 79.4%, while total peripheral resistance fell by 27.9% of the baseline values. In control rats, the changes were smaller (+27.2% and -22.5%, respectively). Stroke volume changed in parallel to cardiac output in both groups. The data suggest that acute blockade of NK-1 receptors increases blood pressure in DOCA-salt rats mainly by an increase in cardiac output. We conclude that endogenous substance P tends to counteract the DOCA-salt-induced elevation of blood pressure by modulating both cardiac output and peripheral resistance.
id UFSP_3ca330319d418b8b967398590e2116d3
oai_identifier_str oai:repositorio.unifesp.br/:11600/43826
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Cardiovascular effects of a specific nonpeptide antagonist of substance-p (nk-1) receptor in doca-salt hypertensionSubstance PNeuropeptidesTachykinins hypertensionSodium-dependentThe neurotransmitter substance P acts also as a potent vasodilator. Its participation in the pathogenesis of deoxycorticosterone acetate (DOCA)-salt hypertension was evaluated by an acute infusion of a newly synthesized, potent, specific nonpeptide antagonist of substance P at the NK-1 receptor, the agent CP 96 345. In conscious unrestrained rats, CP 96 345 induced significant and sustained increases in mean arterial pressure of DOCA-salt rats but only small, transient, and nonsignificant rises in blood pressure of sham-treated control rats. The rise in blood pressure was not accompanied by changes in heart rate. Maximal blood pressure increase in DOCA-salt rats was 31.7+/-14.8 mm Hg. In a second series of experiments, the hemodynamic effects of this antagonist were evaluated under anesthesia in both DOCA-salt and sham-treated control rats by the thermodilution method. During CP 96 345 infusion, sustained increases in cardiac index and stroke volume and decreases in total peripheral resistance were observed in both DOCA-salt and control rats. In DOCA-salt rats, cardiac index rose by 79.4%, while total peripheral resistance fell by 27.9% of the baseline values. In control rats, the changes were smaller (+27.2% and -22.5%, respectively). Stroke volume changed in parallel to cardiac output in both groups. The data suggest that acute blockade of NK-1 receptors increases blood pressure in DOCA-salt rats mainly by an increase in cardiac output. We conclude that endogenous substance P tends to counteract the DOCA-salt-induced elevation of blood pressure by modulating both cardiac output and peripheral resistance.BOSTON UNIV,MED CTR,BOSTON,MAWeb of ScienceAmer Heart AssocBOSTON UNIVUniversidade Federal de São Paulo (UNIFESP)Kohlmann Junior, Osvaldo [UNIFESP]Ginoza, Milton [UNIFESP]Cesaretti, Mario Luis Ribeiro [UNIFESP]Zanella, Maria Teresa [UNIFESP]Ribeiro, Artur Beltrame [UNIFESP]Ramos, Oswaldo Luiz [UNIFESP]Leeman, Susan E.Gavras, IreneGavras, Haralambos [UNIFESP]Tavares, Agostinho [UNIFESP]2018-06-15T17:35:12Z2018-06-15T17:35:12Z1995-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion1186-1189https://doi.org/10.1161/01.HYP.26.6.1186Hypertension. Dallas: Amer Heart Assoc, v. 26, n. 6, p. 1186-1189, 1995.10.1161/01.HYP.26.6.11860194-911Xhttps://repositorio.unifesp.br/handle/11600/43826WOS:A1995TK02300035engHypertensioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-05-07T15:16:21Zoai:repositorio.unifesp.br/:11600/43826Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-05-07T15:16:21Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Cardiovascular effects of a specific nonpeptide antagonist of substance-p (nk-1) receptor in doca-salt hypertension
title Cardiovascular effects of a specific nonpeptide antagonist of substance-p (nk-1) receptor in doca-salt hypertension
spellingShingle Cardiovascular effects of a specific nonpeptide antagonist of substance-p (nk-1) receptor in doca-salt hypertension
Kohlmann Junior, Osvaldo [UNIFESP]
Substance P
Neuropeptides
Tachykinins hypertension
Sodium-dependent
title_short Cardiovascular effects of a specific nonpeptide antagonist of substance-p (nk-1) receptor in doca-salt hypertension
title_full Cardiovascular effects of a specific nonpeptide antagonist of substance-p (nk-1) receptor in doca-salt hypertension
title_fullStr Cardiovascular effects of a specific nonpeptide antagonist of substance-p (nk-1) receptor in doca-salt hypertension
title_full_unstemmed Cardiovascular effects of a specific nonpeptide antagonist of substance-p (nk-1) receptor in doca-salt hypertension
title_sort Cardiovascular effects of a specific nonpeptide antagonist of substance-p (nk-1) receptor in doca-salt hypertension
author Kohlmann Junior, Osvaldo [UNIFESP]
author_facet Kohlmann Junior, Osvaldo [UNIFESP]
Ginoza, Milton [UNIFESP]
Cesaretti, Mario Luis Ribeiro [UNIFESP]
Zanella, Maria Teresa [UNIFESP]
Ribeiro, Artur Beltrame [UNIFESP]
Ramos, Oswaldo Luiz [UNIFESP]
Leeman, Susan E.
Gavras, Irene
Gavras, Haralambos [UNIFESP]
Tavares, Agostinho [UNIFESP]
author_role author
author2 Ginoza, Milton [UNIFESP]
Cesaretti, Mario Luis Ribeiro [UNIFESP]
Zanella, Maria Teresa [UNIFESP]
Ribeiro, Artur Beltrame [UNIFESP]
Ramos, Oswaldo Luiz [UNIFESP]
Leeman, Susan E.
Gavras, Irene
Gavras, Haralambos [UNIFESP]
Tavares, Agostinho [UNIFESP]
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv BOSTON UNIV
Universidade Federal de São Paulo (UNIFESP)
dc.contributor.author.fl_str_mv Kohlmann Junior, Osvaldo [UNIFESP]
Ginoza, Milton [UNIFESP]
Cesaretti, Mario Luis Ribeiro [UNIFESP]
Zanella, Maria Teresa [UNIFESP]
Ribeiro, Artur Beltrame [UNIFESP]
Ramos, Oswaldo Luiz [UNIFESP]
Leeman, Susan E.
Gavras, Irene
Gavras, Haralambos [UNIFESP]
Tavares, Agostinho [UNIFESP]
dc.subject.por.fl_str_mv Substance P
Neuropeptides
Tachykinins hypertension
Sodium-dependent
topic Substance P
Neuropeptides
Tachykinins hypertension
Sodium-dependent
description The neurotransmitter substance P acts also as a potent vasodilator. Its participation in the pathogenesis of deoxycorticosterone acetate (DOCA)-salt hypertension was evaluated by an acute infusion of a newly synthesized, potent, specific nonpeptide antagonist of substance P at the NK-1 receptor, the agent CP 96 345. In conscious unrestrained rats, CP 96 345 induced significant and sustained increases in mean arterial pressure of DOCA-salt rats but only small, transient, and nonsignificant rises in blood pressure of sham-treated control rats. The rise in blood pressure was not accompanied by changes in heart rate. Maximal blood pressure increase in DOCA-salt rats was 31.7+/-14.8 mm Hg. In a second series of experiments, the hemodynamic effects of this antagonist were evaluated under anesthesia in both DOCA-salt and sham-treated control rats by the thermodilution method. During CP 96 345 infusion, sustained increases in cardiac index and stroke volume and decreases in total peripheral resistance were observed in both DOCA-salt and control rats. In DOCA-salt rats, cardiac index rose by 79.4%, while total peripheral resistance fell by 27.9% of the baseline values. In control rats, the changes were smaller (+27.2% and -22.5%, respectively). Stroke volume changed in parallel to cardiac output in both groups. The data suggest that acute blockade of NK-1 receptors increases blood pressure in DOCA-salt rats mainly by an increase in cardiac output. We conclude that endogenous substance P tends to counteract the DOCA-salt-induced elevation of blood pressure by modulating both cardiac output and peripheral resistance.
publishDate 1995
dc.date.none.fl_str_mv 1995-12-01
2018-06-15T17:35:12Z
2018-06-15T17:35:12Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://doi.org/10.1161/01.HYP.26.6.1186
Hypertension. Dallas: Amer Heart Assoc, v. 26, n. 6, p. 1186-1189, 1995.
10.1161/01.HYP.26.6.1186
0194-911X
https://repositorio.unifesp.br/handle/11600/43826
WOS:A1995TK02300035
url https://doi.org/10.1161/01.HYP.26.6.1186
https://repositorio.unifesp.br/handle/11600/43826
identifier_str_mv Hypertension. Dallas: Amer Heart Assoc, v. 26, n. 6, p. 1186-1189, 1995.
10.1161/01.HYP.26.6.1186
0194-911X
WOS:A1995TK02300035
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Hypertension
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 1186-1189
dc.publisher.none.fl_str_mv Amer Heart Assoc
publisher.none.fl_str_mv Amer Heart Assoc
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268360832057344